Mail

Singapore markets closed

Straits Times Index
3,290.70
+24.75(+0.76%)
Nikkei
38,229.11
+155.13(+0.41%)
Hang Seng
18,963.68
+425.87(+2.30%)
FTSE 100
8,433.76
+52.41(+0.63%)
Bitcoin USD
60,920.17
+159.14(+0.26%)
CMC Crypto 200
1,260.89
-97.12(-7.15%)

Nabriva Therapeutics plc (NBRVF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0000

0.0000

(0.00%)

At close: 11:44AM EDT

Currency in USD

Earnings estimate	Current qtr. (Dec 2022)	Next qtr. (Mar 2023)	Current year (2022)	Next year (2023)
No. of analysts	0	0	0	0
Avg. Estimate	0	0	0	0
Low estimate	0	0	0	0
High estimate	0	0	0	0
Year ago EPS	-6	-5	N/A	N/A

Revenue estimate	Current qtr. (Dec 2022)	Next qtr. (Mar 2023)	Current year (2022)	Next year (2023)
No. of analysts	1	1	1	1
Avg. Estimate	10.57M	N/A	36.94M	70.77M
Low estimate	11.04M	12.9M	37.4M	70.77M
High estimate	11.04M	12.9M	37.4M	70.77M
Year ago sales	9.26M	8.02M	28.89M	36.94M
Sales growth (year/est)	14.10%	N/A	27.80%	91.60%

Earnings history	30/12/2021	30/03/2022	29/06/2022	29/09/2022
Est. EPS	-4.75	-4.75	-5	-4.02
Actual EPS	-6	-5	-4.5	-4.21
Difference	-1.25	-0.25	0.5	-0.19
Surprise %	-26.30%	-5.30%	10.00%	-4.70%

EPS trend	Current qtr. (Dec 2022)	Next qtr. (Mar 2023)	Current year (2022)	Next year (2023)
Current estimate	0	0	0	0
7 days ago	-3.91	-3.37	-17.37	-8.76
30 days ago	-3.91	-3.37	-17.37	-8.76
60 days ago	-3.91	-3.37	-17.37	-8.76
90 days ago	-3.91	-3.37	-17.37	-8.76

EPS revisions	Current qtr. (Dec 2022)	Next qtr. (Mar 2023)	Current year (2022)	Next year (2023)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	N/A	N/A	N/A	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	NBRVF	Industry	Sector(s)	S&P 500
Current qtr.	N/A	N/A	N/A	N/A
Next qtr.	N/A	N/A	N/A	N/A
Current year	N/A	N/A	N/A	N/A
Next year	N/A	N/A	N/A	N/A
Next 5 years (per annum)	97.20%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A